Patents by Inventor Matthias Hoffmann

Matthias Hoffmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260100648
    Abstract: A multi-phase circuit includes a plurality of phases respectively corresponding to a plurality of clock phases. To balance respective output currents from the phases, for each phase: in response to an occurrence of a sampling time of that phase, a measurement signal corresponding to a value at the sampling time of the current for that phase is produced using a sampling circuit and provided to the other phases, other measurement signals from the other phases are received, an indicator signal according to whether the measurement signal is greater than an average of the other measurement signals is produced using a comparator circuit, and the output current of the phase is adjusted according to the indicator signal. The plurality of phases may include three or more phases.
    Type: Application
    Filed: October 7, 2024
    Publication date: April 9, 2026
    Inventors: Matthias HOFFMANN, Karsten TROELLER
  • Publication number: 20250333414
    Abstract: This invention relates to compounds of formula (1) and their use in the prevention, delaying and/or treatment of diseases or conditions which can be influenced by STING inhibition.
    Type: Application
    Filed: April 28, 2025
    Publication date: October 30, 2025
    Inventors: Matthias HOFFMANN, Marta BRAMBILLA, Georg DAHMANN, Patrick GROSS, Jun LI, Camilla MAYER, Herbert NAR, Thorsten OOST, Theodor THEIS
  • Publication number: 20250333398
    Abstract: This invention relates to compounds of formula (I) and their use in the prevention, delaying and/or treatment of diseases or conditions which can be influenced by STING inhibition.
    Type: Application
    Filed: April 28, 2025
    Publication date: October 30, 2025
    Inventors: Matthias HOFFMANN, Georg DAHMANN, Patrick GROSS, Jun LI, Herbert NAR, Thorsten OOST
  • Patent number: 12451805
    Abstract: To reduce sub-harmonic oscillations in a Switched-Mode Power Supply (SMPS). a ramp generator circuit of the SMPS produces a ramp signal having an amplitude corresponding to a sensed current through an energy storage device, such as an inductor, of the SMPS. The ramp signal is used to control a duty cycle of the SMPS. The ramp generator circuit may include a reference current circuit, a ramp capacitor, and a discharge circuit to periodically discharge the ramp capacitor. The ramp capacitor may be charged using a charging current produced by combining a feedback current corresponding to the sensed current with a reference current produced by the reference current circuit and may be periodically discharged at a fixed frequency, or may be charged using the reference current and discharged at a time determined according to the feedback current.
    Type: Grant
    Filed: July 12, 2023
    Date of Patent: October 21, 2025
    Assignee: GlobalFoundries U.S. Inc.
    Inventor: Matthias Hoffmann
  • Publication number: 20250023468
    Abstract: To reduce sub-harmonic oscillations in a Switched-Mode Power Supply (SMPS). a ramp generator circuit of the SMPS produces a ramp signal having an amplitude corresponding to a sensed current through an energy storage device, such as an inductor, of the SMPS. The ramp signal is used to control a duty cycle of the SMPS. The ramp generator circuit may include a reference current circuit, a ramp capacitor, and a discharge circuit to periodically discharge the ramp capacitor. The ramp capacitor may be charged using a charging current produced by combining a feedback current corresponding to the sensed current with a reference current produced by the reference current circuit and may be periodically discharged at a fixed frequency, or may be charged using the reference current and discharged at a time determined according to the feedback current.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 16, 2025
    Inventor: Matthias HOFFMANN
  • Patent number: 10947243
    Abstract: The invention relates to new substituted heteroaryls of formula 1 wherein A is selected from the group consisting of N and CH D is selected from the group consisting of CH, N, NH, S and O, E is selected from the group consisting of C and N, T is selected from the group consisting of C and N, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: March 16, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Dahmann, Matthias Hoffmann, Jasna Klicic Badoux, David James Lamb, Clive McCarthy, Spencer Charles R. Napier, Karen Parrish, John Scott, Jennifer L. Swantek Fitzgerald, Edward Walker
  • Publication number: 20190359620
    Abstract: The invention relates to new substituted heteroaryls of formula 1 wherein A is selected from the group consisting of N and CH D is selected from the group consisting of CH, N, NH, S and O, E is selected from the group consisting of C and N, T is selected from the group consisting of C and N, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: August 8, 2019
    Publication date: November 28, 2019
    Inventors: Georg DAHMANN, Matthias HOFFMANN, Jasna KLICIC BADOUX, David James LAMB, Clive MCCARTHY, Spencer Charles R. NAPIER, Karen PARRISH, John SCOTT, Jennifer L. Swantek FITZGERALD, Edward WALKER
  • Patent number: 10235753
    Abstract: A method for automatic recognition of at least one anatomical landmark in a hollow organ of a patient is provided. The method includes providing an image dataset of the hollow organ, establishing or providing a three-dimensional mesh of a surface of the hollow organ from the image dataset, and determining a centerline of the mesh by skeletization. At least one feature is determined for each of a plurality of points on the centerline. A classifier pre-trained on the at least one feature is used for detecting candidates for the at least one anatomical landmark from the plurality of points. The candidates are grouped together with a distance from one another below a threshold. At least one specification determined from the anatomy of the hollow organ is used for confirming or rejecting the candidates for the at least one anatomical landmark. One or more candidates are defined as an anatomical landmark.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: March 19, 2019
    Assignee: SIEMENS HEALTHCARE GMBH
    Inventors: Matthias Hoffmann, Norbert Strobel
  • Patent number: 10155751
    Abstract: The invention relates to new substituted heteroaryls of formula 1 or of formula 1? wherein A is either N or CH, wherein R2 is selected from the group consisting of —C1-3-alkyl, —C1-3-haloalkyl, F, Br, Cl, wherein Y is selected from —O— or —CH2—, and wherein R3 is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: December 18, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Matthias Hoffmann, Georg Dahmann, Christian Gnamm, Daniel Robert Fandrick, John Scott, Clive McCarthy
  • Publication number: 20180148433
    Abstract: The invention relates to new substituted heteroaryls of formula 1 or of formula 1? wherein A is either N or CH, wherein R2 is selected from the group consisting of —C1-3-alkyl, —C1-3-haloalkyl, F, Br, Cl, wherein Y is selected from —O— or —CH2—, and wherein R3 is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: November 10, 2017
    Publication date: May 31, 2018
    Inventors: Matthias Hoffmann, Georg Dahmann, Christian Gnamm, Daniel Robert Fandrick, John Scott, Clive McCarthy
  • Publication number: 20180072744
    Abstract: The invention relates to new substituted heteroaryls of formula 1 wherein A is selected from the group consisting of N and CH D is selected from the group consisting of CH, N, NH, S and O, E is selected from the group consisting of C and N, T is selected from the group consisting of C and N, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: November 20, 2017
    Publication date: March 15, 2018
    Inventors: Georg DAHMANN, Matthias HOFFMANN, Jasna KLICIC, David James LAMB, Clive MCCARTHY, Spencer Charles R. NAPIER, Karen PARRISH, John SCOTT, Jennifer L. Swantek FITZGERALD, Edward WALKER
  • Patent number: 9914735
    Abstract: The invention relates to new substituted heteroaryls of formula (1), wherein A is selected from the group consisting of N and CH, D is CH, E is selected from the group consisting of C and N, T is C, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: March 13, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Dahmann, Matthias Hoffmann, Jasna Klicic, David James Lamb, Clive McCarthy, Spencer Charles R. Napier, Karen Parrish, John Scott, Jennifer L. Swantek Fitzgerald, Edward Walker
  • Patent number: 9845314
    Abstract: The invention relates to new substituted heteroaryls of formula 1 or of formula 1? wherein A is either N or CH, wherein R2 is selected from the group consisting of —C1-3-alkyl, —C1-3-haloalkyl, F, Br, Cl, wherein Y is selected from —O— or —CH2—, and wherein R3 is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: December 19, 2017
    Assignee: Boehrnger Ingelheim International GmbH
    Inventors: Matthias Hoffmann, Georg Dahmann, Christian Gnamm, Daniel Fandrick, John Scott, Clive McCarthy
  • Publication number: 20170270663
    Abstract: A method for automatic recognition of at least one anatomical landmark in a hollow organ of a patient is provided. The method includes providing an image dataset of the hollow organ, establishing or providing a three-dimensional mesh of a surface of the hollow organ from the image dataset, and determining a centerline of the mesh by skeletization. At least one feature is determined for each of a plurality of points on the centerline. A classifier pre-trained on the at least one feature is used for detecting candidates for the at least one anatomical landmark from the plurality of points. The candidates are grouped together with a distance from one another below a threshold. At least one specification determined from the anatomy of the hollow organ is used for confirming or rejecting the candidates for the at least one anatomical landmark. One or more candidates are defined as an anatomical landmark.
    Type: Application
    Filed: March 15, 2017
    Publication date: September 21, 2017
    Inventors: Matthias Hoffmann, Norbert Strobel
  • Publication number: 20170151753
    Abstract: A sandwich element includes a base element and a structural element. The structural element forms a soft touch surface of the sandwich element, the structural element contains at least two functional layers, one of the functional layers is a soft touch layer and another of the functional layers is a decorative layer forming the soft touch surface. The soft touch layer is disposed between the decorative layer and the base element and a fire-retardant layer is disposed in the interior of the sandwich element.
    Type: Application
    Filed: November 28, 2016
    Publication date: June 1, 2017
    Inventors: Andreas HARMS, Matthias HOFFMANN
  • Publication number: 20170073333
    Abstract: The invention relates to new substituted heteroaryls of formula 1 or of formula 1? wherein A is either N or CH, wherein R2 is selected from the group consisting of —C1-3-alkyl, —C1-3-haloalkyl, F, Br, Cl, wherein Y is selected from —O— or —CH2—, and wherein R3 is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: September 2, 2016
    Publication date: March 16, 2017
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Matthias HOFFMANN, Georg DAHMANN, Christian GNAMM, Daniel FANDRICK, John SCOTT, Clive McCARTHY
  • Publication number: 20170008896
    Abstract: The invention relates to new substituted heteroaryls of formula 1 wherein A is selected from the group consisting of N and CH D is selected from the group consisting of CH, N, NH, E is C, T is selected from the group consisting of C and N, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: March 12, 2015
    Publication date: January 12, 2017
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Georg DAHMANN, Matthias HOFFMANN, Jasna KLICIC, David James LAMB, Clive McCARTHY, Spencer NAPIER, Karen PARRISH, John SCOTT, Jennifer L. Swantek FITZGERALD, Edward WALKER
  • Patent number: 9517589
    Abstract: An adjustable mechanism for a motor vehicle is used to adjust an adjustable element in a motor vehicle, especially a seating part. The mechanism includes a spindle nut comprising an axis, the spindle nut co-operating with a thread spindle and comprising external toothing on the external surface thereof which is in contact with an additional drive element. The external toothing of the spindle nut is formed by recesses in the external surface of the spindle nut which are inwardly turned in a radial manner, the teeth depths thereof diminishing in the direction of at least one axial end of the spindle nut.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: December 13, 2016
    Assignee: Brose Fahrzeugteile GmbH & Co. KG, Coburg
    Inventors: Matthias Hoffmann, Andrea Bauersachs, Andreas Prause
  • Publication number: 20160244446
    Abstract: The invention relates to new substituted heteroaryls of formula (1), wherein A is selected from the group consisting of N and CH, D is CH, E is selected from the group consisting of C and N, T is C, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: March 12, 2015
    Publication date: August 25, 2016
    Inventors: Georg DAHMANN, Matthias HOFFMANN, Jasna KLICIC, David James LAMB, Clive MCCARTHY, Spencer Charles R. NAPIER, Karen PARRISH, John SCOTT, Jennifer L. Swantek FITZGERALD, Edward WALKER
  • Patent number: D769864
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: October 25, 2016
    Assignee: REWE Markt GmbH
    Inventors: Matthias Hoffmann, Michael Reuter